Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry

RS Khedar, R Gupta, K Sharma, K Mittal… - BMJ open, 2022 - bmjopen.bmj.com
Objectives To determine association of biomarkers—high-sensitivity C reactive protein
(hsCRP), D-dimer, interleukin-6 (IL-6), lactic dehydrogenase (LDH), ferritin and neutrophil …

[PDF][PDF] Genetic Susceptibility to Severe Forms of COVID-19: What We Learned in 2022

R Benmansour, MR Tagajdid, S Elkochri… - Saudi J. Pathol …, 2023 - researchgate.net
Host genetics of COVID-19 patients is constantly evolving and may play an important role in
the management of hospitalized patients and the identification of new biomarkers. In 2022 …

Recognition of Differentially Expressed Molecular Signatures and Pathways Associated with COVID-19 Poor Prognosis in Glioblastoma Patients

FA Alzahrani, MF Khan, V Ahmad - International Journal of Molecular …, 2023 - mdpi.com
Glioblastoma (GBM) is a type of brain cancer that is typically very aggressive and difficult to
treat. Glioblastoma cases have been reported to have increased during COVID-19. The …

Concentraciones séricas de interleuquina 6 y su valor pronóstico de letalidad en adultos mayores con Covid-19

NIA Marquez, ALD Cañarte - … FIPCAEC (Fomento de la investigación y …, 2022 - fipcaec.com
La pandemia de COVID-19, ha afectado a todas las edades, etnias o género. El Objetivo del
estudio fue analizar evidencias científicas sobre las concentraciones séricas de la …

Biomarkers and Outcomes in Hospitalized Covid-19 Patients: A Prospective Registry

RS Khedar, R Gupta, KK Sharma, K Mittal… - medRxiv, 2022 - medrxiv.org
Objectives To determine association of biomarkers high sensitivity C-reactive protein
(hsCRP), D-dimer, interleukin-6 (IL-6), lactic dehydrogenase (LDH), ferritin and neutrophil …